Clinical Trial Update: VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Vinorelbine, Carboplatin, and Trastuzumab (VinCaT) in advanced HER2-positive metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Trastuzumab (trastuzumab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN